Back
Blueprint Medicines Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43
BPMC
Blueprint Medicines
Last Price:
$88.53
Seasonality Move:
7.76%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and BPMC is experiencing slight selling pressure.
Blueprint Medicines Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.1 | Buy |
20-day SMA: | 84.11 | Buy |
50-day SMA: | 88.24 | Buy |
200-day SMA: | 94.67 | Sell |
8-day EMA: | 86.39 | Buy |
20-day EMA: | 85.79 | Buy |
50-day EMA: | 88.74 | Sell |
200-day EMA: | 92.18 | Sell |
Blueprint Medicines Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 55.57 | Buy |
Chaikin Money Flow: | -41477 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (81.56 - 89.08) | Buy |
Bollinger Bands (100): | (84.71 - 103.35) | Sell |
Blueprint Medicines Technical Analysis
Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 88.48 while BPMC 8-day simple moving average is 86.10, which is a Buy signal.
-
The stock price of BPMC is 88.48 while Blueprint Medicines 20-day SMA is 84.11, which makes it a Buy.
-
Blueprint Medicines 50-day simple moving average is 88.24 while BPMC share price is 88.48, making it a Buy technically.
-
BPMC stock price is 88.48 and Blueprint Medicines 200-day simple moving average is 94.67, creating a Sell signal.
BPMC Technical Analysis vs Fundamental Analysis
Sell
43
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a SellThe current Blueprint Medicines [BPMC] share price is $88.48. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
Blueprint Medicines Stock Info
Market Cap:
5.7B
Price in USD:
88.48
Share Volume:
573.5K
Blueprint Medicines 52-Week Range
52-Week High:
121.90
52-Week Low:
73.04
Sell
43
Blueprint Medicines (BPMC)
is a Sell
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?The Blueprint Medicines stock price is 88.48 USD today.
-
Will BPMC stock go up or go down?Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators
-
Is Blueprint Medicines overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is overvalued.
Is Blueprint Medicines Stock a Buy?
-
Blueprint Medicines share price is 88.48 while BPMC 8-day exponential moving average is 86.39, which is a Buy signal.
-
The stock price of BPMC is 88.48 while Blueprint Medicines 20-day EMA is 85.79, which makes it a Buy.
-
Blueprint Medicines 50-day exponential moving average is 88.74 while BPMC share price is 88.48, making it a Sell technically.
-
BPMC stock price is 88.48 and Blueprint Medicines 200-day simple moving average is 92.18, creating a Sell signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.63 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.32 per share, and an increase next year of $2.76 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
-
BPMC Moving Average Covergence Divergence (MACD) indicator is -0.48, suggesting Blueprint Medicines is a Sell
-
Blueprint Medicines Relative Strength Index (RSI) is 55.57, which suggest Blueprint Medicines is overbought
-
The Bollinger Bands (25) for Blueprint Medicines is (81.56 - 89.08), which suggest Blueprint Medicines is a Sell
-
The Bollinger Bands (100) for Blueprint Medicines is (84.71 - 103.35), which suggest Blueprint Medicines is a Sell
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.